| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/27/2008 | EP1383386B1 Anti-inflammatory herbal composition |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1322665B1 Hiv peptides from conserved regions in gag p17 and their applications, such as vaccines |
| 08/27/2008 | EP1228086B1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/27/2008 | EP1115418B1 Diagnosis of cancers associated with viral infections using aglycoprotein 10B |
| 08/27/2008 | EP1027437B1 Uses of the wnt-1 induced secreted polypeptide wisp-1 |
| 08/27/2008 | EP0827410B1 Method for introducing and expressing genes in animal cells |
| 08/27/2008 | CN101253274A Prostate stem cell markers |
| 08/27/2008 | CN101253267A Materials and methods for respiratory disease control in canines |
| 08/27/2008 | CN101253264A 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ |
| 08/27/2008 | CN101253199A Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins |
| 08/27/2008 | CN101253198A Antibody produced using ostrich and method for production thereof |
| 08/27/2008 | CN101252951A Anti-IL-23 antibodies, compositions, methods and uses |
| 08/27/2008 | CN101252950A Immunoglobulins comprising predominantly a GLCNACMAN3GLCNAC2 sugar form |
| 08/27/2008 | CN101252946A Methods for the rapid expansion of antigen specific T-cells |
| 08/27/2008 | CN101249265A Intravenous injection employ persons hepatitis B immune globulin and method of preparing the same |
| 08/27/2008 | CN101249264A Tuberculosis and medicament-resistant tubercular personalized yelk polyclone antibody and method of preparing the same and applications |
| 08/27/2008 | CN101249263A Application of pig immune globulin for producing medicament for preventing and controlling dog infection of digestive canal disease |
| 08/27/2008 | CN101249262A Targeted nano granule of humanization monoclonal antibody trastuzumab modified packaged toxin protein, and preparation and applications thereof |
| 08/27/2008 | CN101249261A Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same |
| 08/27/2008 | CN101249260A Preparation of vaccines for preventing piglet diarrhoea |
| 08/27/2008 | CN100413970C Hepatitis B surface antigen blending gene and protein for carboxyl terminal containing precursor S2 immune decision cluster |
| 08/27/2008 | CN100413888C Soluble polypeptides |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/27/2008 | CN100413537C SARS coronary virus full virus vaccine |
| 08/27/2008 | CN100413536C Hydrophobia split vaccine for human body |
| 08/26/2008 | US7417136 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 08/26/2008 | US7417130 DNA library comprising nucleotide sequences coding polypeptide containing leucine repeats for monitoring binding and regulation of ligand and cofactor interactions |
| 08/26/2008 | US7417113 Antitumor agents; anticancer agents; antibody binding |
| 08/26/2008 | US7417025 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions |
| 08/26/2008 | US7416878 Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416853 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 08/26/2008 | US7416852 detection of the immunocomplexes between the antibodies and the polypeptides indicates the presence of antibodies specific for Porphyromonas gingivalis in the test sample |
| 08/26/2008 | US7416849 HBM variants that modulate bone mass and lipid levels |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | US7416846 A vaccine composition comprising virus-like particles (VLPs) containing L1 proteins or functional L1 protein derivatives from human papillomavirus (HPV) 16, HPV 18, HPV 31 and HPV 45 genotypes and an adjuvant;anticarcinogenic agents; antumor agents; viricides |
| 08/26/2008 | US7416839 Immunoassay; for therapeutic treatment of Bovine spongiform encephalopathy (BSE) in cows, Scrapie disease in sheep and Creutzfeldt-Jacob syndrome in humans |
| 08/26/2008 | US7416745 Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 08/26/2008 | US7416734 Vaccines for Mycoplasma bovis and methods of use |
| 08/26/2008 | US7416733 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins |
| 08/26/2008 | US7416732 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 08/26/2008 | US7416731 diagnosis and treatment of hair loss; producing the antibody by immunizing an animal with a Hairless antigen; conjugating the Hairless protein to a carrier |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | US7416729 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen |
| 08/26/2008 | US7416728 Growth blocking agents |
| 08/26/2008 | US7416727 administering to the mammal a variant of a parent polypeptide comprising an Fc region; mediates antibody-dependent cell-mediated cytotoxicity (ADCC) in the presence of human effector cells more effectively than the parent polypeptide |
| 08/26/2008 | US7416726 Cytotoxicity; therapeutic antibody |
| 08/26/2008 | US7416725 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth |
| 08/26/2008 | CA2400007C Immunization of an individual against carcinoma and the preliminary stages thereof |
| 08/26/2008 | CA2374667C Synthetic ligation reassembly in directed evolution |
| 08/26/2008 | CA2331465C Improvements relating to encapsulation of bioactive agents |
| 08/26/2008 | CA2289761C Method of making microencapsulated dna for vaccination and gene therapy |
| 08/26/2008 | CA2235225C Nima interacting proteins |
| 08/21/2008 | WO2008101231A2 Methods and compositions for treating and diagnosing kidney disease |
| 08/21/2008 | WO2008101179A2 Use of sucrose to suppress mannitol-induced protein aggregation |
| 08/21/2008 | WO2008101175A2 Protein formulations containing sorbitol |
| 08/21/2008 | WO2008101060A1 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor |
| 08/21/2008 | WO2008101037A1 Method to treat inflammation |
| 08/21/2008 | WO2008100995A1 Humanized anti-cd100 antibodies |
| 08/21/2008 | WO2008100805A2 Anti-robo4 antibodies and uses therefor |
| 08/21/2008 | WO2008100609A1 A novel antitoxin and vaccine platform based on nodavirus vlps |
| 08/21/2008 | WO2008100598A2 A method for enhancing t cell response |
| 08/21/2008 | WO2008100584A2 Compositions and methods of treating neoplasia |
| 08/21/2008 | WO2008100562A2 Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells |
| 08/21/2008 | WO2008100508A2 Puumala virus full-length m segment-based dna vaccines |
| 08/21/2008 | WO2008100464A1 Viral vectors and methods of use |
| 08/21/2008 | WO2008100384A2 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 08/21/2008 | WO2008100328A2 METHODS AND COMPOSITIONS FOR TARGETING gC1qR/p32 |
| 08/21/2008 | WO2008100290A2 Recombinant rhinovirus vectors |
| 08/21/2008 | WO2008099969A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same |
| 08/21/2008 | WO2008099928A1 Placental protein having action of regulating protease activity and its related gene |
| 08/21/2008 | WO2008099920A1 Therapeutic agent for interstitial pulmonary disease comprising anti-hmgb-1 antibody |
| 08/21/2008 | WO2008099917A1 Agent for suppressing rejection in organ transplantation comprising anti-hmgb-1 antibody |
| 08/21/2008 | WO2008099913A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient |
| 08/21/2008 | WO2008099908A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | WO2008099829A1 Method for formation of intestinal adhesion in experimental animal, method for production of experimental animal having intestinal adhesion, method for screening of intestinal adhesion-preventing agent, and intestinal adhesion-preventing agent |
| 08/21/2008 | WO2008099278A2 Pharmaceutical compositions and methods for ccr5 antagonists |
| 08/21/2008 | WO2008099188A1 Binding members for ige molecules |
| 08/21/2008 | WO2008099185A1 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 08/21/2008 | WO2008099001A1 Use of a leukocyte diminishing or inactivating agent in combination with bacterially-mediated tumor treatment |
| 08/21/2008 | WO2008098909A1 Prevention and treatment of sub-clinical pcvd |
| 08/21/2008 | WO2008098749A2 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof |
| 08/21/2008 | WO2008098484A1 Recombinant l1 proteins of human papilloma virus and uses thereof |
| 08/21/2008 | WO2008082719A3 Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors |
| 08/21/2008 | WO2008081014A3 Process for manufacturing vaccines |
| 08/21/2008 | WO2008080091A3 Activation of rig-i pathway |
| 08/21/2008 | WO2008077413B1 Dna vaccines for fish |
| 08/21/2008 | WO2008068048A3 A novel passive vaccine for candida infections |
| 08/21/2008 | WO2008067995A8 Means and method for raising improved immune response |
| 08/21/2008 | WO2008060581A3 Compositions including triciribine and trastuzumab and methods of use thereof |
| 08/21/2008 | WO2008058127A9 Agonist trkb antibodies and uses thereof |
| 08/21/2008 | WO2008054539A3 Diagnosis of anthrax infection by detection of capsular antigen in urine |
| 08/21/2008 | WO2008051424A3 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 08/21/2008 | WO2008049424A3 Pharmaceutical composition for the treatment of allergic diseases |
| 08/21/2008 | WO2008046003A3 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 08/21/2008 | WO2008043104A3 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 08/21/2008 | WO2008005084B1 Methods to prevent and treat diseases |
| 08/21/2008 | WO2007137279A3 Herv-k antigens, antibodies, and methods |
| 08/21/2008 | WO2007109110A3 Methods for increasing the size of animals using needleless delivery constructs |